您的位置: 首页 > 2025年12月 第56卷 第12期 > 文字全文
2023年7月 第38卷 第7期11
目录

经皮冠状动脉介入治疗后恐动症患者不良心理健康状态的影响因素分析

Analysis of the influencing factors of adverse psychological health status in patients with kinesiophobia after percutaneous coronary intervention

来源期刊: 广州医药 | 1712-1723 发布时间:2025-12-20 收稿时间:2026/1/27 11:59:25 阅读量:42
作者:
关键词:
经皮冠状动脉介入治疗恐动症抑郁焦虑压力影响因素
percutaneous coronary interventionkinesiophobiadepressionanxietystressinfluencing factors
DOI:
10. 20223 / j. cnki. 1000-8535. 2025. 12. 014
收稿时间:
2025-02-11 
修订日期:
 
接收日期:
 
引用总数:
0  
       目的   识别经皮冠状动脉介入治疗(PCI)后恐动症患者抑郁、焦虑和压力的影响因素。方法   采用横断面研究,纳入780例行PCI术后恐动症患者。应用系列量表评估恐动症患者的不良心理健康状况、生活质量、自我感受负担、社会支持和运动自我效能,并通过问卷收集了患者的社会人口学数据。线性回归和Logistic回归用于识别抑郁、焦虑和压力等不良心理状态的影响因素,应用中介分析探索潜在的中介机制。结果  271例(34.7%)、304例(39.0%)和153例(19.6%)恐动症患者存在不同程度的抑郁、焦虑和压力。恐动症患者的抑郁、焦虑和压力水平呈正相关。线性回归和Logistic分析结果表明,较高的家庭月收入与较高的抑郁水平相关(线性回归:β为0.908和1.937;Logistic:OR2.05和5.47),社会支持程度与抑郁水平呈负相关(线性回归:β=-0.079;Logistic:OR=0.93)。单身/离异/寡居患者的焦虑水平显著高于已婚患者(线性回归:β=1.613;Logistic:OR=2.28)。与家庭月收入低于5 000元者相比,家庭月收入为5 000~10 000元之间的患者的压力水平较高(线性回归:β=1.065;Logistic:OR=3.14)。此外,自我感受负担较重的患者具有更高的压力水平(线性回归:β=0.077;Logistic:OR=1.05)。中介分析结果表明,焦虑和压力是社会支持/自我感受负担与抑郁之间关联的潜在中介因子。结论  PCI术后恐动症患者广泛存在心理健康问题,其家庭月收入、年龄、婚姻状况、生活方式和病史等因素对患者的不良心理健康状态具有显著影响。医务人员应关注这些患者的心理健康状况及影响因素,制定综合管理策略以改善其预后。
       Objective  To identify the risk factors associated with depression,anxiety  and  stress in  patients with kinesiophobia after percutaneous coronary intervention(PCI).Methods  In this cross-sectional study,780 patients who developed kinesiophobia after undergoing PCI were enrolled.A series of scales were used to assess the psychological health status,quality of life,self-perceived burden,social support,and exercise self-efficacy of patients with kinesiophobia,and socio-demographic data of the patients were collected through a questionnaire.Linear regression analyses and Logistic regression analyses were used to identify risk factors of adverse psychological outcomes,including depression,anxiety,and stress.Furthermore,mediation analysis was employed to explore the potential mediating mechanisms.Results  Among the 780 patients with kinesiophobia,271(34.7%),304(39.0%)and 153(19.6%)were found to have varying degrees of depression,anxiety,and stress,respectively.The levels of depression,anxiety and stress in patients with kinesiophobia were positively correlated with each other.The results of both linear regression and Logistic regression analyses indicated that higher levels of family monthly income were associated with higher levels of depression(linear:β=0.908 and 1.937;Logistic:OR=2.05 and 5.47),while the degree of social support was negatively correlated with depression levels(linear:β=-0.079;Logistic:OR=0.93).For patients who were single,divorced or widowed,their levels of anxiety were significantly higher than those of married patients(linear:β=1.613;Logistic:OR=2.28).Compared to patients with a monthly household income of less than 5 000 yuan,those with a monthly income between 5 000 and 10 000 yuan reported higher levels of stress(linear:β=1.065;Logistic:OR=3.14).Additionally,patients who perceived a higher personal burden also experienced greater stress(linear:β=0.077;Logistic:OR=1.05).Mediation analysis indicated that anxiety and stress were potential mediating factors in the relationship between social support/self-perceived burden and depression.Conclusions  This study  reported the widespread psychological health issues among patients with kinesiophobia after PCI and the interactions between these issues.Factors such as monthly household income,age,marital status,lifestyle and medical  history were found to  be significantly associated with these negative psychological outcomes.Clinicians and nurses should focus on the psychological health and influencing factors of these patients and develop comprehensive management strategies to improve their prognosis.
        冠状动脉粥样硬化性心脏病(冠心病)是全球人类死亡的主要原因之一,对患者和社会均造成了严重的负担[1-3]。经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)作为治疗冠心病的主要方法,因其疗效显著及微创等优点而得到广泛应用[4]。研究表明,PCI术后进行康复锻炼可显著降低冠状动脉疾病患者的并发症和死亡率[5]。然而,PCI术后患者对康复锻炼的依从性往往较差,许多患者会出现“运动恐惧症”(恐动症)的心理障碍,主要表现为对身体活动的过度、非理性的恐惧和对疼痛或受伤的敏[6]
       当前,围绕PCI术后恐动症的相关研究尚不充分,且主要集中于探索影响患者恐动症发生与否的危险因素。王海珍等[7]发现,自理能力、是否合并心力衰竭、急诊手术以及久坐行为等是患者PCI术后恐动症发生的影响因素。Zhu等[8]的研究显示PCI术后恐动症的发生与患者的受教育程度、冠心病临床分型、运动习惯、慢性病资源利用、疾病认知和自我掌控感等因素显著相关。Chen等[9]通过半结构化访谈认为,PCI患者恐动症的发生主要来源于心理压力的增加、运动不确定性的增加、自我效能感降低和支持系统不足。
       既往研究显示,PCI手术容易诱发患者出现不同程度的心理健康问题,如抑郁、焦虑、压力等,且这些不良心理健康状态在PCI后恐动症患者中更为常见[10-12]。PCI术后恐动症患者能否以积极的态度去应对康复锻炼中的挑战,并保持良好的锻炼依从性,对其预后水平具有重要影响。然而,迄今为止,国内外较少研究关注PCI术后恐动症患者不良心理健康状态的影响因素。因此,本研究旨在探索PCI术后恐动症患者抑郁、焦虑和压力的分布状况及其影响因素,以期为临床医生和护士制定PCI术后个性化的康复管理计划提供理论依据,改善患者的心理健康和预后。

1  资料与方法

1.1  研究对象

        本研究采用便利抽样法,招募了2022年11月1日—2023年12月31日期间来自广东省8家三甲医院行PCI治疗的患者。8家三甲医院包括广东省人民医院、广东省第二人民医院、广州市第一人民医院、中山大学附属第七医院、广东医科大学附属医院、惠州市中心人民医院、梅州市人民医院和粤北人民医院。以上8家医院覆盖了广东省珠三角地区、粤北、粤西等多个区域,其所在地区的人口特征、文化习俗、地理环境和医疗水平均为广东省不同地区的典型代表,可使本研究的样本更具代表性。
       研究对象的纳入标准如下:(1)符合世界卫生组织或国际心脏病学会对冠状动脉粥样硬化性心脏病的诊断标准,且成功接受PCI治疗;(2)PCI术后6~48 h;(3)年龄为18~80岁;(4)经汉化版的心脏病患者运动恐惧量表评估为患有恐动症。研究对象的排除标准如下:(1)存在重度语言、认知或视力障碍;(2)患有其他重大疾病,如癌症、精神疾病和脑血管疾病等;(3)存在严重肢体运动障碍或其他导致无法活动的重大疾病,如瘫痪、骨折、截肢和深静脉血栓;(4)因急性或重度心力衰竭需绝对卧床休息;(5)怀孕或哺乳期妇女。本研究已在中国临床试验注册中心注册(注册号:ChiCTR2300070396)注册,并获得广州第一人民医院伦理委员会批准(伦理批件号:K-2022-140-01)。所有研究对象均已知情同意、自愿参与调查并签署了知情同意书。

1.2  样本量计算

       根据本研究PCI术后恐动症患者抑郁(34.7%)、焦虑(39.0%)和压力(19.6%)的患病率情况,带入横断面研究样本量计算公式n=Zα 2 p(1-p)/d2 ,设置α=0.05,d=0.2p,采用双侧检验,计算得出所需最小样本量分别为181、151和394例。根据本研究的数据结果,应用PASS 15.0 样本量计算软件,选择Multiple Regression using Effect Size模块,设置α=0.05,power=0.8,依据附表2~4提供的多因素分析结果,依次带入相应的kC、kT与f 2 参数,计算得出:以抑郁为结局的回归分析至少需要464例样本量(power=0.800 4),以焦虑为结局的回归分析至少需要480例样本量(power=0.800 2),以压力为结局的回归分析至少需要318例样本量(power=0.8005)。本研究共纳入780例研究对象,基于80%统计效能,满足最小样本量的需求。

1.3  问卷调查与量表评估

       本研究通过使用问卷星平台设计调查问卷以收集研究对象的社会人口学信息和相关临床资料。收集的数据包括性别、年龄、婚姻状况、子女数量、教育程度、职业、家庭月收入、医疗费用支付方式、吸烟史、饮酒史、高血压史、糖尿病史、疾病认知水平、植入支架数量、是否参与心脏康复以及近1周的身体活动情况。
        本研究使用汉化版心脏病患者运动恐惧量表(Tampa Scale of Kinesiophobia-Short Version for Heart Disease,TSK-SV Heart)评估PCI治疗后患者的运动恐惧水平,其中TSK-SV Heart得分≥38分(范围17~68分)者被定义为患有恐动症[13]采用中文版运动自我效能量表(Chinese Self-Efficacy for Exercise Scale,SEE-C)评估患者的运动自我效能(范围0~90分,分值越高提示运动自我效能感越强)[14];使用社会支持评定量表(Social Support Rating Scale,SSRS)评估患者的社会支持水平(范围12~66分,分值越高提示社会支持水平越好)[15];采用自我感受负担量表(Self-Perceived Burden Scale,SPBS)评估患者的感知负担(范围10~50分,得分越高表明自我感受负担越重)[16];使用健康调查简表(Short Form Health Survey-36,SF-36)评估患者的生活质量(范围0~100分,分值越高提示生活质量越好)[17];应用汉化版抑郁、焦虑和压力量表-21(Depression,Anxiety,and Stress Scale-21,DASS-21)评估患者的心理健康状态[18]。DASS-21量表包括三个子量表——抑郁、焦虑和压力,每个子量表的得分范围为0~42分。得分越高,表示抑郁、焦虑或压力水平越高。根据量表得分,抑郁程度可分为4个等级:正常(0~9分)、轻度(10~13分)、中度(14~20分)和重度(≥21分)。焦虑程度被定义为正常(0~7分)、轻度(8~9分)、中度(10~14分)和重度(≥15分)。压力程度的分类包括正常(0~14 分)、轻度(15~18分)、中度(19~25分)和重度(≥26分)[19]
       本研究结合文献调研、专业医师意见(介入科、康复科、心理科等)及预调查情况来确定纳入研究的变量。在调查开展前,由研究者对所有调查员进行统一培训,保证各项调查表填写的规范化;在研究对象填写问卷的过程中,由专业人员陪同指导,提高问卷的回收率和有效率;各分中心采用统一的调查程序和方法,并由主中心成员定期走访分中心监督工作并进行质量控制,以保证各分中心调查的一致性;所有数据由双人交叉核实检查,保证问卷真实有效,数据准确可靠。本研究共发放问卷970份,回收970份(回收率100%)。依据以下标准筛选有效问卷:(1)关键条目缺失<5%;(2)逻辑一致性检验通过;(3)无重复提交或规律性作答。最终有效问卷970份(有效率100%),其中780份经量表确认为患有恐动症者被纳入本研究后续分析。

1.4  统计学分析

       应用Shapiro-Wilk检验评估连续型变量的正态性。对于符合正态分布的连续型变量,以表示,多组间比较采用单因素方差分析。对于不符合正态分布的连续型变量,以MP25P75)表示,组间比较采用Kruskal-Wallis H检验。分类变量以n(%)表示,组间比较使用χ 2 检验或Fisher确切概率法。通过单因素和多因素线性回归分析,探索恐动症患者抑郁、焦虑和压力得分的影响因素。使用多元Logistic回归分析探索恐动症患者抑郁、焦虑和压力程度的影响因素。采用基于线性回归的中介效应分析探索关联间潜在的中介因素。使用SPSS 25软件包进行统计学分析,P<0.05视为差异具有统计学意义。

2  结 果

2.1  一般资料

       本研究共纳入了780例行PCI术后恐动症患者。根据DASS-21的评估结果,271例(34.7%)患者被评估为存在不同程度的抑郁, 304 例(39.0%)患者存在焦虑,153例(19.6%)患者的压力水平存在异常。所有研究对象的社会人口学资料与临床信息详见表1,研究对象不良心理健康程度的分布详见附表1(附表1~7见 https://pan.baidu.com/s/1kvDThKfgPh_M4O6gPNUJcwpwd=gzyy)。

1   研究对象的社会人口学资料与临床信息    (n = 780)

变量

n%/MP25-P75

性别

 

603 (77.3)

177 (22.7)

年龄

 

18~65

415 (53.2)

66~79

316 (40.5)

80

49 (6.3)

婚姻状况

 

已婚

710 (91.0)

单身/离异/寡居

70 (9.0)

家庭月收入

 

< 5 000

277 (35.5)

5 000~10 000

400 (51.3)

≥ 10 000

103 (13.2)

受教育程度

 

小学及以下

173 (22.2)

中学

326 (41.8)

高中及以上

281 (36.0)

职业

 

自由职业者

120 (15.4)

工人

100 (12.8)

职员

104 (13.3)

农民

198 (25.4)

退休者

258 (33.1)

医疗费用支付方式

 

新型农村合作医疗

316 (40.5)

城乡居民基本医疗保险

399 (51.2)

其他

65 (8.3)

子女数量

 

1

202 (25.9)

2

306 (39.2)

≥3

272 (34.9)

吸烟

 

478 (61.3)

302 (38.7)

饮酒

 

593 (76.0)

187 (24.0)

对疾病的了解程度

 

不了解

99 (12.7)

一般了解

572 (73.3)

非常了解

109 (14.0)

高血压

 

337 (43.2)

443 (56.8)

糖尿病

 

526 (67.4)

254 (32.6)

支架数量

 

1

381 (48.8)

2

262 (33.6)

≥ 3

137 (17.6)

参与心脏康复

 

393 (50.4)

387 (49.6)

一周平均活动频率

 

1次

372 (47.7)

1~3次

323 (41.4)

3次以上

85 (10.9)

运动自我效能得分/分

30.00 (14.00,49.00)

社会支持得分/分

38.00 (35.00,43.00)

生活质量得分/分

358.16 (320.37,421.91)


2.2  影响恐动症患者抑郁、焦虑和压力分值的单因素和多因素线性回归分析

       单因素线性回归分析显示,抑郁、焦虑及压力得分三者之间均呈正相关。除此之外,与三者均呈线性相关的变量还包括婚姻状况、家庭月收入、职业、医疗费用支付方式、吸烟、糖尿病、运动自我效能得分、社会支持得分及自我感受负担得分。抑郁、焦虑与压力的单因素线性分析结果详见附表2~4。
       将单因素分析识别的潜在关联变量( P<0.05)纳入多因素线性回归模型后,结果显示(见附表2~4):当以抑郁得分为结局变量时,家庭月收入超过5 000元(β为0.908和1.937,P为0.001和<0.001)、从事工人(β=1.059,P=0.010)或职员工作(β=0.845,P=0.041)、进行中等强度体育活动(β=0.482,P=0.036)、较高的焦虑得分(β=0.446,P<0.001)、较高的压力得分(β=0.426,P<0.001)和较低的社会支持得分(β=-0.079,P<0.001)与较高的抑郁水平显著相关。以焦虑得分为结局时,未婚(β=1.613,P=0.001)、使用其他支付方式(β=1.817,P<0.001)、较高的压力得分(β=0.251,P<0.001)、较高的抑郁得分(β =0.564,P<0.001)、较高的生活质量得分(β=0.005,P<0.001)和较高的自我感受负担得分(β=0.065,P=0.001)与较高的焦虑水平显著相关。而家庭月收入超过10 000元(β=-0.849,P=0.048)和对疾病较高的认知水平(β=-1.333,P=0.004)则与较低的焦虑水平相关。对于压力,多因素回归分析结果显示,家庭月收入在5 000~10 000元之间β=1.065,P=0.001)、较高的抑郁(β=0.584,P<0.001)和焦虑(β=0.285,P<0.001)得分、较高的自我感受负担得分(β=0.077,P<0.001)和较低的社会支持得分(β=-0.052,P=0.038)与较高的压力水平显著相关。所有多因素分析的显著结果汇总于表2。

2 影响经皮冠状动脉介入治疗后恐动症患者抑郁、焦虑和压力得分的多因素线性回归分析

不良心理

变量

B

SE

β

t

P

95%CI

抑郁

家庭月收入

 

 

 

 

 

 

 

< 5 000

 

 

 

 

 

REF

 

5 000~10 000

0.908

0.277

0.059

3.275

0.001

0.364~1.452

 

≥ 10 000

1.937

0.380

0.086

5.09

<0.001

1.190~2.684

 

职业

 

 

 

 

 

 

 

自由职业者

 

 

 

 

 

REF

 

工人

1.059

0.408

0.047

2.597

0.010

0.258~1.859

 

职员

0.845

0.413

0.037

2.045

0.041

0.034~1.656

 

农民

0.265

0.378

0.015

0.700

0.484

-0.477~1.007

 

退休者

0.18

0.350

0.011

0.514

0.607

-0.507~0.866

 

一周平均活动频率

 

 

 

 

 

 

 

1次

 

 

 

 

 

REF

 

1~3次

0.482

0.230

0.031

2.097

0.036

0.031~0.933

 

3次以上

0.018

0.366

0.001

0.049

0.961

-0.700~0.736

 

压力得分

0.426

0.027

0.434

15.777

<0.001

0.373~0.478

 

焦虑

0.446

0.028

0.426

15.72

<0.001

0.391~0.502

 

社会支持得分

-0.079

0.021

-0.067

-3.659

<0.001

-0.121~-0.036

焦虑

婚姻状况

 

 

 

 

 

 

 

已婚

 

 

 

 

 

REF

 

单身/离异/寡居

1.613

0.463

0.063

3.486

0.001

0.705~2.520

 

家庭月收入

 

 

 

 

 

 

 

< 5 000

 

 

 

 

 

REF

 

5 000~10 000

-0.376

0.306

-0.026

-1.23

0.219

-0.976~0.224

 

≥ 10 000

-0.849

0.428

-0.04

-1.983

0.048

-1.690~-0.008

 

医疗费用支付方式

 

 

 

 

 

 

 

新型农村合作医疗

 

 

 

 

 

REF

 

城乡居民基本医疗保险

0.556

0.331

0.038

1.682

0.093

-0.093~1.205

 

其他

1.817

0.502

0.069

3.619

<0.001

0.831~2.804

 

对疾病的了解程度

 

 

 

 

 

 

 

不了解

 

 

 

 

 

REF

 

一般了解

-0.739

0.371

-0.045

-1.991

0.047

-1.468~-0.010

 

非常了解

-1.333

0.458

-0.063

-2.914

0.004

-2.232~-0.435

 

压力得分

0.251

0.033

0.268

7.598

<0.001

0.186~0.315

 

抑郁得分

0.564

0.035

0.59

16.153

<0.001

0.495~0.632

 

生活质量得分

0.005

0.001

0.062

3.691

<0.001

0.002~0.008

 

自我感受负担

0.065

0.02

0.067

3.291

0.001

0.026~0.104

压力

家庭月收入

 

 

 

 

 

 

 

< 5 000

 

 

 

 

 

REF

 

5 000~10 000

1.065

0.32

0.068

3.329

0.001

0.437~1.693

 

≥ 10 000

0.169

0.45

0.007

0.376

0.707

-0.714~1.053

 

焦虑得分

0.285

0.037

0.266

7.716

<0.001

0.212~0.357

 

抑郁得分

0.584

0.037

0.572

15.845

<0.001

0.512~0.656

 

社会支持得分

-0.052

0.025

-0.043

-2.075

0.038

-0.101~-0.003

 

自我感受负担得分

0.077

0.021

0.074

3.682

<0.001

0.036~0.119

2.3  影响恐动症患者不良心理健康程度的多元Logistic回归分析

       根据DASS-21评分,恐动症患者的抑郁、焦虑和压力均被分为四个等级:正常、轻度、中度和重度。三种心理状态的多元Logistic回归分析结果见附表5~7,所有显著结果汇总于表3中。多元Logistic回归分析发现,与低收入家庭患者相比,中收入家庭(OR=2.05,95%CI:1.09~3.86,P=0.026)和高收入家庭(OR=5.47,95%CI2.51~11.90,P<0.001)患者更可能出现较高等级的抑郁。此外,接受过心脏康复治疗的患者OR=1.70,95%CI:1.02~2.83,P=0.040)也更易出现较重的抑郁。较高的压力得分(OR=1.23,95%CI:1.17~1.30,P<0.001)、焦虑得分OR=1.31,95%CI:1.24~1.39,P<0.001)和自我感受负担得分(OR=1.04,95%CI:1.01~1.08,P=0.036)是高水平抑郁的危险因素。相反,使用其他支付系统(OR=0.36,95%CI:0.15~0.89,P =0.028)、高血压(OR =0.58,95% CI0.36~0.95,P=0.031)、较高的社会支持水平OR=0.93,95%CI:0.88~0.98,P=0.004)和较好的生活质量(OR=0.99,95%CI:0.99~0.99,P=0.003)则与较低的抑郁水平相关。
       以焦虑程度为因变量的分析显示,单身/离异/寡居(OR=2.28,95%CI:1.15~4.54,P=0.019)、农民(OR=2.40,95%CI:1.10~5.28,P=0.029)、较高的抑郁得分(OR=1.39,95%CI:1.31~1.47,P<0.001)和压力得分(OR=1.15,95%CI1.09~1.21,P<0.001)可能是焦虑的危险因素。就压力而言,66~79岁(OR=1.86,95%CI1.06~3.26,P=0.031)、家庭月收入在5 000~10 000元之间(OR =3.14, 95% CI:1.51~6.50,P =0.002)、较高的焦虑得分(OR =1.10,95%CI:1.04~1.16,P=0.001)、较高的抑郁得分OR=1.22,95%CI:1.15~1.30,P<0.001)和较高的自我感受负担得分(OR=1.05,95%CI1.01~1.10,P=0.035)均是高度压力的危险因素;而退休(OR=0.38,95%CI:0.15~0.97,P=0.043)和生育≥3个子女(OR=0.45,95%CI0.20~0.99,P=0.046)则是高等级压力的保护因素。

3 影响经皮冠状动脉介入治疗后恐动症患者不良心理程度的多元Logistic回归分析

不良心理

变量

B

SE

Wald χ2

P

OR (95%CI)

抑郁

家庭月收入

 

 

 

 

 

 

< 5 000

 

 

 

 

REF

 

5 000~10 000

0.719

0.322

4.971

0.026

2.05 (1.09~3.86)

 

≥ 10 000

1.700

0.396

18.375

<0.001

5.47 (2.51~11.90)

 

医疗费用支付方式

 

 

 

 

 

 

新型农村合作医疗

 

 

 

 

REF

 

城乡居民基本医疗保险

-0.644

0.334

3.72

0.054

0.52 (0.27~1.01)

 

其他

-1.007

0.457

4.853

0.028

0.36 (0.15~0.89)

 

高血压

-0.542

0.251

4.653

0.031

0.58 (0.36~0.95)

 

参与心脏康复

0.532

0.259

4.22

0.040

1.70 (1.02~2.83)

 

压力得分

0.208

0.027

58.948

<0.001

1.23 (1.17~1.30)

 

焦虑得分

0.270

0.029

88.822

<0.001

1.31 (1.24~1.39)

 

自我运动效能得分

0.005

0.008

0.357

0.550

1.01 (0.99~1.02)

 

社会支持得分

-0.074

0.026

8.337

0.004

0.93 (0.88~0.98)

 

生活质量得分

-0.004

0.001

8.932

0.003

0.99 (0.99~0.99)

 

自我感受负担得分

0.042

0.020

4.408

0.036

1.04 (1.01~1.08)

焦虑

婚姻状况

 

 

 

 

 

 

已婚

 

 

 

 

REF

 

单身/离异/寡居

0.825

0.351

5.509

0.019

2.28 (1.15~4.54)

 

职业

 

 

 

 

 

 

自由职业者

 

 

 

 

REF

 

工人

0.156

0.403

0.149

0.699

1.17 (0.53~2.58)

 

职员

-0.103

0.427

0.058

0.809

0.90 (0.39~2.08)

 

农民

0.877

0.401

4.788

0.029

2.40 (1.10~5.28)

 

退休者

0.294

0.405

0.529

0.467

1.34 (0.61~2.97)

 

压力得分

0.138

0.025

30.973

<0.001

1.15 (1.09~1.21)

 

抑郁得分

0.327

0.029

124.056

<0.001

1.39 (1.31~1.47)

压力

年龄/岁

 

 

 

 

 

 

18~65

 

 

 

 

REF

 

66~79

0.620

0.287

4.676

0.031

1.86 (1.06~3.26)

 

80

0.689

0.593

1.349

0.245

1.99 (0.62~6.36)

 

家庭月收入

 

 

 

 

 

 

< 5 000

 

 

 

 

REF

 

5 000~10 000

1.143

0.371

9.458

0.002

3.14 (1.51~6.50)

 

≥ 10 000

0.807

0.441

3.34

0.068

2.24 (0.94~5.32)

 

职业

 

 

 

 

 

 

自由职业者

 

 

 

 

REF

 

工人

0.071

0.442

0.025

0.873

1.07 (0.45~2.55)

 

职员

-0.26

0.448

0.337

0.562

0.77 (0.32~1.86)

 

农民

-0.286

0.45

0.403

0.526

0.75 (0.31~1.82)

 

退休者

-0.964

0.477

4.087

0.043

0.38 (0.15~0.97)

 

子女数量

 

 

 

 

 

 

1

 

 

 

 

REF

 

2

-0.035

0.323

0.012

0.913

0.97 (0.51~1.82)

 

≥3

-0.800

0.401

3.977

0.046

0.45 (0.20~0.99)

 

焦虑得分

0.097

0.028

11.786

0.001

1.10 (1.04~1.16)

 

抑郁得分

0.199

0.031

40.192

<0.001

1.22 (1.15~1.30)

 

自我感受负担得分

0.048

0.023

4.462

0.035

1.05 (1.01~1.10)

2.4  中介效应分析

       中介结果显示,在社会支持水平(暴露)、自我感受负担程度(暴露)与抑郁之间的关联中,焦虑的中介比例分别为70.6%(95%CI61.2~81.0)和76.3%(95%CI:69.1~83.0)。此外,压力也可显著调节社会支持水平、自我感受负担与抑郁之间的关系,其中介比例分别为75.8%(95%CI:66.0~87.0)和78.3%(95%CI70.2~87.0)(表4)。在以焦虑和压力为结局的相关关联的中介分析中,本研究未发现任何显著的中介因素。

4 经皮冠状动脉介入治疗后恐动症患者社会支持/自我感受负担与抑郁相关性的中介分析

暴露

中介

直接效应 β (95%CI)

间接效应 β (95%CI)

总效应 β (95%CI)

中介比例(%)

社会支持

焦虑

-0.146 (-0.206~-0.090)

-0.351 (-0.422~-0.290)

-0.498 (-0.574~-0.420)

70.6 (61.2~81.0)

自我感受负担

焦虑

0.119 (0.079~0.160)

0.383 (0.336~0.440)

0.502 (0.439~0.570)

76.3 (69.1~83.0)

社会支持

压力

-0.120 (-0.177~-0.060)

-0.377 (-0.446~-0.310)

-0.498 (-0.568~-0.430)

75.8 (66.0~87.0)

自我感受负担

压力

0.109 (0.061~0.160)

0.393 (0.343~0.450)

0.502 (0.441~0.570)

78.3 (70.2~87.0)


3  讨 论

       既往针对PCI术后恐动症患者的研究较少,且主要集中于探索影响恐动症的相关因素。迄今为止,尚缺乏仅在PCI术后恐动症患者中开展的旨在探索不良心理健康状态影响因素的相关研究。
       本研究显示,抑郁症状较为严重的恐动症患者通常来自中高收入家庭、接受过心脏康复治疗,并且具有较高水平的压力、焦虑、自我感受负担以及较低水平的社会支持程度。既往研究表明,抑郁症状受到个人、家庭和环境等多种因素的影响,其中压力、焦虑和手术史是常见的抑郁危险因素[20]。与一般认知不同的是,本研究发现高收入家庭的患者抑郁水平较高,原因可能在于高收入家庭患者对自身的健康和治疗结果抱有较高的期望,若出现健康问题或治疗效果不如预期,更容易产生情绪低落和抑郁。
        焦虑是一种更常见的不良心理状况。本研究发现单身/离异/寡居者、从事农业工作的患者、对疾病认知较低的患者,以及经历较高程度的抑郁、压力和自我感受负担的患者,更可能出现较为严重的焦虑症状。既往研究发现婚姻关系可能有助于缓解个体的焦虑和抑郁,这可能与伴侣的陪伴和照顾有关[21]。农民作为体力劳动者,相较于自由职业者具有更大的体力劳动需求和经济压力,因此可能会在PCI术后发展出更严重的焦虑症状。此外,较高的疾病认知水平与焦虑评分呈负相关,这提示可以通过对患者进行疾病相关知识的培训,来缓解患者的焦虑症状。
        本研究表明,对于恐动症患者而言,高龄、较高的焦虑、抑郁、自我感受负担水平均与更高的压力程度相关。年长患者由于身体机能衰退,在术后恢复过程中可能存在更大的压力,这与既往研究的发现相似[22]。本研究中,育有三胎及以上子女对患者的压力情绪可起到保护作用。这可能是更多的子女数量可以为患者提供更多的家庭支持和照护,子女们轮流承担患者照护的这种分工合作机制不仅减轻了患者的压力,也减轻了家庭整体的压力。焦虑、抑郁等负面情绪会加剧压力症状,这与前文关于抑郁和焦虑的分析一致,提示抑郁、焦虑和压力之间的相互作用关系,三者往往相伴相生,且任意一种不良心理状态的产生均易诱发另外两种,因此,医护人员与看护人员对患者的心理健康状态应给予持续关注。值得注意的是,患者较为严重的负面情绪往往会影响其对医护人员的信任感,导致治疗配合度差、后期康复干预困难[23]。因此,对PCI患者积极开展早期的心理健康干预同样具有重要意义。
        中介分析结果显示,焦虑和压力在社会支持/自我感受负担得分与抑郁风险的关联中均起到了一定的中介作用。社会支持水平的提升可缓解焦虑和压力情绪,从而降低抑郁风险。既往研究表明,良好的社会支持有助于促进心理健康[24-26]多项横断面研究发现,增加社会支持可预防老年人抑郁症状[27-29],欧盟健康访谈调查基于24个欧洲国家的研究也显示,社会支持与抑郁等不良心理状态之间存在较强的相关性[30]。相反,自我感受负担水平的增加可能加剧焦虑和压力,从而增加抑郁风险。全球多项研究表明,自我感受负担是患者面临的最重要的社会压力源,可能导致抑郁、焦虑、沮丧和自责等负面情绪反应,还可能影响患者的治疗决策、治疗效果和生活质量[31-33]因此,PCI术后恐动症患者应注重减少自我感受负担,尤其在经历焦虑和压力时,应及时疏导、调整心态,防止抑郁的发生。
       本研究的主要优势在于以下三点:首先,研究对象来自广东省多家具有代表性的医院,且样本量较大、收集的数据较为全面,可提高研究结论的可靠性;其次,本研究采用了一系列国际公认的调查量表,所有研究人员均在研究开展前接受了系统的培训,以规范研究的实施过程,提高研究质量;第三,围绕抑郁、焦虑与压力三个变量,本研究分别从得分水平(连续型变量)与病情程度(分类变量)两个角度,应用两种回归模型(线性回归与逻辑回归)展开数据分析,并校正了潜在的混杂因素,以降低研究中潜在的偏倚。并通过中介分析深入探索了可能调节PCI术后恐动症患者抑郁、焦虑和压力发展的潜在机制。然而,本研究也存在一些局限性:首先,使用自我报告的调查问卷可能引入信息偏倚;其次,尽管本研究已纳入了来自广东省不同区域的8家三甲医院的病例,但由于广东省地域辽阔,无法实现全面覆盖,故样本的代表性仍存在不足;最后,本研究作为一项横断面研究,无法推断关联之间的因果关系,未来,尚需要进一步开展相关的前瞻性探索。
       依据本研究的发现,针对PCI术后恐动症患者,医护人员与临床照护人员应采用以下应对方案:(1)对患者的心理健康状态给予持续的关注与定期监测,尤其是高龄、农民、单身/离异/寡居及既往接受过康复治疗者,一旦发现问题,尽早对患者开展积极的心理干预,如帮助他们识别和改变负面思维模式、教授患者一些基本的情绪管理技巧(深呼吸、冥想、放松训练等)、必要时在专业医生指导下使用药物等,以防心理问题进一步加剧;(2)着重提高患者的社会支持水平,鼓励家属积极参与患者的康复过程,提供情感支持,帮助患者建立健康的生活方式,促进患者之间建立互助小组并分享个人经验,增强患者的心理韧性;(3)注重降低患者的自我感受负担,帮助患者了解恐动症的性质,让患者意识到他们可以掌控自己的康复过程,并帮助患者设定易于实现的小目标,逐步增加他们的运动量,并不断肯定他们在恢复中取得的进展;(4)医护人员及其科室应提高患者与家属对疾病的认知,定期组织疾病科普讲座或发放疾病科普手册,积极解答患者对病情的疑问,消除对疾病的误解,并宣讲科学化康复训练的重要性,帮助患者建立信心,增强他们对疾病的科学理解。
       综上所述,本研究首次关注了PCI术后恐动症患者抑郁、焦虑和压力的影响因素,结果显示抑郁、焦虑和压力受患者职业、婚姻状况、年龄、家庭收入、社会支持和自我感受负担水平等因素的影响。这些发现可为临床医生和护士在制定PCI术后恐动症患者的康复计划时提供理论依据,也可为未来围绕恐动症开展的相关研究提供线索。
1、ZHOU%E2%80%83M%EF%BC%8CWANG%E2%80%83H%EF%BC%8CZENG%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8EMortality%EF%BC%8C%0AmORbidity%EF%BC%8Cand%E2%80%83%20risk%E2%80%83%20facto%20rs%E2%80%83%20in%E2%80%83%20China%E2%80%83%20and%E2%80%83%20its%E2%80%83%0Aprovinces%EF%BC%8C1990-2017%EF%BC%9AA%E2%80%83systematic%E2%80%83analysis%E2%80%83for%E2%80%83the%E2%80%83%0AGlobal%E2%80%83Burden%E2%80%83of%E2%80%83Disease%E2%80%83Study%E2%80%832017%EF%BC%BBJ%EF%BC%BD%EF%BC%8ELancet%EF%BC%8C%0A2019%EF%BC%8C394%EF%BC%8810204%EF%BC%89%EF%BC%9A1145-1158%EF%BC%8EZHOU%E2%80%83M%EF%BC%8CWANG%E2%80%83H%EF%BC%8CZENG%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8EMortality%EF%BC%8C%0AmORbidity%EF%BC%8Cand%E2%80%83%20risk%E2%80%83%20facto%20rs%E2%80%83%20in%E2%80%83%20China%E2%80%83%20and%E2%80%83%20its%E2%80%83%0Aprovinces%EF%BC%8C1990-2017%EF%BC%9AA%E2%80%83systematic%E2%80%83analysis%E2%80%83for%E2%80%83the%E2%80%83%0AGlobal%E2%80%83Burden%E2%80%83of%E2%80%83Disease%E2%80%83Study%E2%80%832017%EF%BC%BBJ%EF%BC%BD%EF%BC%8ELancet%EF%BC%8C%0A2019%EF%BC%8C394%EF%BC%8810204%EF%BC%89%EF%BC%9A1145-1158%EF%BC%8E
2、陶丽,文若兰,范婷,等.冠心病患者心脏康复参与意愿的调查分析[J].广州医药,2024,55(7):723-729.陶丽,文若兰,范婷,等.冠心病患者心脏康复参与意愿的调查分析[J].广州医药,2024,55(7):723-729.
3、ALPERT%E2%80%83J%E2%80%83S%EF%BC%8ENew%E2%80%83%20cORonary%E2%80%83%20heart%E2%80%83%20disease%E2%80%83%20risk%E2%80%83%0AfactORs%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAm%E2%80%83J%E2%80%83Med%EF%BC%8C2023%EF%BC%8C136%EF%BC%884%EF%BC%89%EF%BC%9A331-%0A332%EF%BC%8EALPERT%E2%80%83J%E2%80%83S%EF%BC%8ENew%E2%80%83%20cORonary%E2%80%83%20heart%E2%80%83%20disease%E2%80%83%20risk%E2%80%83%0AfactORs%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAm%E2%80%83J%E2%80%83Med%EF%BC%8C2023%EF%BC%8C136%EF%BC%884%EF%BC%89%EF%BC%9A331-%0A332%EF%BC%8E
4、%E2%80%83%20PICCOLO%E2%80%83R%EF%BC%8CBRUZZESE%E2%80%83D%EF%BC%8CMAURO%E2%80%83C%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0APopulation%E2%80%83trends%E2%80%83in%E2%80%83%20rates%E2%80%83of%E2%80%83%20percutaneous%E2%80%83coronary%E2%80%83%0Arevascularization%E2%80%83%20fOR%E2%80%83%20acute%E2%80%83%20coronary%E2%80%83%20syndromes%E2%80%83%0Aassociated%E2%80%83with%E2%80%83the%E2%80%83COVID-19%E2%80%83outbreak%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0ACirculation%EF%BC%8C2020%EF%BC%8C141%EF%BC%8824%EF%BC%89%EF%BC%9A2035-2037%EF%BC%8E%E2%80%83%20PICCOLO%E2%80%83R%EF%BC%8CBRUZZESE%E2%80%83D%EF%BC%8CMAURO%E2%80%83C%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0APopulation%E2%80%83trends%E2%80%83in%E2%80%83%20rates%E2%80%83of%E2%80%83%20percutaneous%E2%80%83coronary%E2%80%83%0Arevascularization%E2%80%83%20fOR%E2%80%83%20acute%E2%80%83%20coronary%E2%80%83%20syndromes%E2%80%83%0Aassociated%E2%80%83with%E2%80%83the%E2%80%83COVID-19%E2%80%83outbreak%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0ACirculation%EF%BC%8C2020%EF%BC%8C141%EF%BC%8824%EF%BC%89%EF%BC%9A2035-2037%EF%BC%8E
5、HOOLE%E2%80%83S%E2%80%83P%EF%BC%8CBAMBROUGH%E2%80%83P%EF%BC%8ERecent%E2%80%83advances%E2%80%83in%E2%80%83%0Apercutaneous%E2%80%83coronary%E2%80%83intervention%EF%BC%BBJ%EF%BC%BD%EF%BC%8EHeart%EF%BC%8C%0A2020%EF%BC%8C106%EF%BC%8818%EF%BC%89%EF%BC%9A1380-1386%EF%BC%8EHOOLE%E2%80%83S%E2%80%83P%EF%BC%8CBAMBROUGH%E2%80%83P%EF%BC%8ERecent%E2%80%83advances%E2%80%83in%E2%80%83%0Apercutaneous%E2%80%83coronary%E2%80%83intervention%EF%BC%BBJ%EF%BC%BD%EF%BC%8EHeart%EF%BC%8C%0A2020%EF%BC%8C106%EF%BC%8818%EF%BC%89%EF%BC%9A1380-1386%EF%BC%8E
6、DABEK%E2%80%83J%EF%BC%8CKNAPIK%E2%80%83A%EF%BC%8CGALLERT-KOPYTO%E2%80%83W%EF%BC%8C%0Aet%E2%80%83al%EF%BC%8EFear%E2%80%83of%E2%80%83movement%EF%BC%88kinesiophobia%EF%BC%89-%E2%80%83%20an%E2%80%83%0Aunderestimated%E2%80%83%20problem%E2%80%83in%E2%80%83Polish%E2%80%83%20patients%E2%80%83at%E2%80%83various%E2%80%83%0Astages%E2%80%83of%E2%80%83coronary%E2%80%83artery%E2%80%83disease%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAnn%E2%80%83Agric%E2%80%83%0AEnviron%E2%80%83Med%EF%BC%8C2020%EF%BC%8C27%EF%BC%881%EF%BC%89%EF%BC%9A56-60%EF%BC%8EDABEK%E2%80%83J%EF%BC%8CKNAPIK%E2%80%83A%EF%BC%8CGALLERT-KOPYTO%E2%80%83W%EF%BC%8C%0Aet%E2%80%83al%EF%BC%8EFear%E2%80%83of%E2%80%83movement%EF%BC%88kinesiophobia%EF%BC%89-%E2%80%83%20an%E2%80%83%0Aunderestimated%E2%80%83%20problem%E2%80%83in%E2%80%83Polish%E2%80%83%20patients%E2%80%83at%E2%80%83various%E2%80%83%0Astages%E2%80%83of%E2%80%83coronary%E2%80%83artery%E2%80%83disease%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAnn%E2%80%83Agric%E2%80%83%0AEnviron%E2%80%83Med%EF%BC%8C2020%EF%BC%8C27%EF%BC%881%EF%BC%89%EF%BC%9A56-60%EF%BC%8E
7、黎钰晴,袁丽,李静,等.急性心肌梗死患者经皮冠状动脉介入术后早期恐动症现状及影响因素分析[J].中国康复,2024,39(10):611-616.黎钰晴,袁丽,李静,等.急性心肌梗死患者经皮冠状动脉介入术后早期恐动症现状及影响因素分析[J].中国康复,2024,39(10):611-616.
8、ZHU%E2%80%83Y%EF%BC%8CWANG%E2%80%83Z%EF%BC%8CSU%E2%80%83T%EF%BC%8Cet%E2%80%83al%EF%BC%8EKinesophobia%E2%80%83%0Aand%E2%80%83its%E2%80%83%20related%E2%80%83factors%E2%80%83in%E2%80%83%20patients%E2%80%83after%E2%80%83%20percutaneous%E2%80%83%0Acoronary%E2%80%83intervention%EF%BC%9AA%E2%80%83cross-sectional%E2%80%83study%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0AJ%E2%80%83Clin%E2%80%83Nurs%EF%BC%8C2024%EF%BC%8C33%EF%BC%8812%EF%BC%89%EF%BC%9A4692-4707%EF%BC%8EZHU%E2%80%83Y%EF%BC%8CWANG%E2%80%83Z%EF%BC%8CSU%E2%80%83T%EF%BC%8Cet%E2%80%83al%EF%BC%8EKinesophobia%E2%80%83%0Aand%E2%80%83its%E2%80%83%20related%E2%80%83factors%E2%80%83in%E2%80%83%20patients%E2%80%83after%E2%80%83%20percutaneous%E2%80%83%0Acoronary%E2%80%83intervention%EF%BC%9AA%E2%80%83cross-sectional%E2%80%83study%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0AJ%E2%80%83Clin%E2%80%83Nurs%EF%BC%8C2024%EF%BC%8C33%EF%BC%8812%EF%BC%89%EF%BC%9A4692-4707%EF%BC%8E
9、CHEN%E2%80%83L%EF%BC%8CLI%E2%80%83J%E2%80%83Y%EF%BC%8CREN%E2%80%83Z%E2%80%83Q%EF%BC%8Cet%E2%80%83al%EF%BC%8EIdentifying%E2%80%83%0Afactors%E2%80%83contributing%E2%80%83to%E2%80%83kinesiophobia%E2%80%83in%E2%80%83patients%E2%80%83post%02percutaneous%E2%80%83coronary%E2%80%83intervention%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83%0ANurs%EF%BC%8C2025%EF%BC%8C24%EF%BC%881%EF%BC%89%EF%BC%9A176%EF%BC%8ECHEN%E2%80%83L%EF%BC%8CLI%E2%80%83J%E2%80%83Y%EF%BC%8CREN%E2%80%83Z%E2%80%83Q%EF%BC%8Cet%E2%80%83al%EF%BC%8EIdentifying%E2%80%83%0Afactors%E2%80%83contributing%E2%80%83to%E2%80%83kinesiophobia%E2%80%83in%E2%80%83patients%E2%80%83post%02percutaneous%E2%80%83coronary%E2%80%83intervention%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83%0ANurs%EF%BC%8C2025%EF%BC%8C24%EF%BC%881%EF%BC%89%EF%BC%9A176%EF%BC%8E
10、DING%E2%80%83L%EF%BC%8CLI%E2%80%83C%EF%BC%8CCHEN%E2%80%83L%EF%BC%8Cet%E2%80%83al%EF%BC%8ESummary%E2%80%83of%E2%80%83%20best%E2%80%83evidence%E2%80%83to%E2%80%83address%E2%80%83kinesiophobia%E2%80%83post%E2%80%83percutaneous%E2%80%83%0Acoronary%E2%80%83intervention%EF%BC%9AAn%E2%80%83evidence-based%E2%80%83review%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPatient%E2%80%83Prefer%E2%80%83Adherence%EF%BC%8C2024%EF%BC%8818%EF%BC%89%EF%BC%9A%0A2007-2017%EF%BC%8EDING%E2%80%83L%EF%BC%8CLI%E2%80%83C%EF%BC%8CCHEN%E2%80%83L%EF%BC%8Cet%E2%80%83al%EF%BC%8ESummary%E2%80%83of%E2%80%83%20best%E2%80%83evidence%E2%80%83to%E2%80%83address%E2%80%83kinesiophobia%E2%80%83post%E2%80%83percutaneous%E2%80%83%0Acoronary%E2%80%83intervention%EF%BC%9AAn%E2%80%83evidence-based%E2%80%83review%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPatient%E2%80%83Prefer%E2%80%83Adherence%EF%BC%8C2024%EF%BC%8818%EF%BC%89%EF%BC%9A%0A2007-2017%EF%BC%8E
11、%E2%80%83%20LIU%E2%80%83L%EF%BC%8CYANG%E2%80%83Q%EF%BC%8CLI%E2%80%83T%EF%BC%8Cet%E2%80%83al%EF%BC%8EPrevalence%E2%80%83%20and%E2%80%83%0Ainfluencing%E2%80%83factors%E2%80%83of%E2%80%83%20kinesiophobia%E2%80%83in%E2%80%83%20patients%E2%80%83with%E2%80%83%0Aheart%E2%80%83disease%EF%BC%9AA%E2%80%83meta-analysis%E2%80%83and%E2%80%83systematic%E2%80%83review%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8ESci%E2%80%83Rep%EF%BC%8C2024%EF%BC%8C14%EF%BC%881%EF%BC%89%EF%BC%9A18956%EF%BC%8E%E2%80%83%20LIU%E2%80%83L%EF%BC%8CYANG%E2%80%83Q%EF%BC%8CLI%E2%80%83T%EF%BC%8Cet%E2%80%83al%EF%BC%8EPrevalence%E2%80%83%20and%E2%80%83%0Ainfluencing%E2%80%83factors%E2%80%83of%E2%80%83%20kinesiophobia%E2%80%83in%E2%80%83%20patients%E2%80%83with%E2%80%83%0Aheart%E2%80%83disease%EF%BC%9AA%E2%80%83meta-analysis%E2%80%83and%E2%80%83systematic%E2%80%83review%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8ESci%E2%80%83Rep%EF%BC%8C2024%EF%BC%8C14%EF%BC%881%EF%BC%89%EF%BC%9A18956%EF%BC%8E
12、%E2%80%83%20CHEN%E2%80%83M%EF%BC%8CLIU%E2%80%83M%EF%BC%8CGUO%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8EEffects%E2%80%83%20of%E2%80%83%0AXinkeshu%E2%80%83tablets%E2%80%83on%E2%80%83coronary%E2%80%83%20heart%E2%80%83%20disease%E2%80%83%20patients%E2%80%83%0Acombined%E2%80%83with%E2%80%83anxiety%E2%80%83and%E2%80%83depression%E2%80%83symptoms%E2%80%83after%E2%80%83%0Apercutaneous%E2%80%83coronary%E2%80%83intervention%EF%BC%9AA%E2%80%83meta-analysis%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPhytomedicine%EF%BC%8C2022%EF%BC%88104%EF%BC%89%EF%BC%9A154243%EF%BC%8E%E2%80%83%20CHEN%E2%80%83M%EF%BC%8CLIU%E2%80%83M%EF%BC%8CGUO%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8EEffects%E2%80%83%20of%E2%80%83%0AXinkeshu%E2%80%83tablets%E2%80%83on%E2%80%83coronary%E2%80%83%20heart%E2%80%83%20disease%E2%80%83%20patients%E2%80%83%0Acombined%E2%80%83with%E2%80%83anxiety%E2%80%83and%E2%80%83depression%E2%80%83symptoms%E2%80%83after%E2%80%83%0Apercutaneous%E2%80%83coronary%E2%80%83intervention%EF%BC%9AA%E2%80%83meta-analysis%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPhytomedicine%EF%BC%8C2022%EF%BC%88104%EF%BC%89%EF%BC%9A154243%EF%BC%8E
13、BACK%E2%80%83M%EF%BC%8CJANSSON%E2%80%83B%EF%BC%8CCIDER%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8EValidation%E2%80%83%0Aof%E2%80%83a%E2%80%83questionnaire%E2%80%83to%E2%80%83detect%E2%80%83kinesiophobia%EF%BC%88fear%E2%80%83%20of%E2%80%83%0Amovement%EF%BC%89in%E2%80%83patients%E2%80%83with%E2%80%83coronary%E2%80%83artery%E2%80%83disease%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Rehabil%E2%80%83Med%EF%BC%8C2012%EF%BC%8C44%EF%BC%884%EF%BC%89%EF%BC%9A363-369%EF%BC%8EBACK%E2%80%83M%EF%BC%8CJANSSON%E2%80%83B%EF%BC%8CCIDER%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8EValidation%E2%80%83%0Aof%E2%80%83a%E2%80%83questionnaire%E2%80%83to%E2%80%83detect%E2%80%83kinesiophobia%EF%BC%88fear%E2%80%83%20of%E2%80%83%0Amovement%EF%BC%89in%E2%80%83patients%E2%80%83with%E2%80%83coronary%E2%80%83artery%E2%80%83disease%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Rehabil%E2%80%83Med%EF%BC%8C2012%EF%BC%8C44%EF%BC%884%EF%BC%89%EF%BC%9A363-369%EF%BC%8E
14、WONG%E2%80%83E%E2%80%83M%E2%80%83L%EF%BC%8CLEUNG%E2%80%83D%E2%80%83Y%E2%80%83P%EF%BC%8CSIT%E2%80%83J%E2%80%83W%E2%80%83H%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AProspective%E2%80%83validation%E2%80%83of%E2%80%83the%E2%80%83Chinese%E2%80%83version%E2%80%83of%E2%80%83the%E2%80%83%0Aself-efficacy%E2%80%83for%E2%80%83%20exercise%E2%80%83%20scale%E2%80%83%20among%E2%80%83middle-aged%E2%80%83%0Apatients%E2%80%83with%E2%80%83coronary%E2%80%83heart%E2%80%83disease%EF%BC%BBJ%EF%BC%BD%EF%BC%8ERehabil%E2%80%83%0ANurs%EF%BC%8C2020%EF%BC%8C45%EF%BC%882%EF%BC%89%EF%BC%9A74-79%EF%BC%8EWONG%E2%80%83E%E2%80%83M%E2%80%83L%EF%BC%8CLEUNG%E2%80%83D%E2%80%83Y%E2%80%83P%EF%BC%8CSIT%E2%80%83J%E2%80%83W%E2%80%83H%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AProspective%E2%80%83validation%E2%80%83of%E2%80%83the%E2%80%83Chinese%E2%80%83version%E2%80%83of%E2%80%83the%E2%80%83%0Aself-efficacy%E2%80%83for%E2%80%83%20exercise%E2%80%83%20scale%E2%80%83%20among%E2%80%83middle-aged%E2%80%83%0Apatients%E2%80%83with%E2%80%83coronary%E2%80%83heart%E2%80%83disease%EF%BC%BBJ%EF%BC%BD%EF%BC%8ERehabil%E2%80%83%0ANurs%EF%BC%8C2020%EF%BC%8C45%EF%BC%882%EF%BC%89%EF%BC%9A74-79%EF%BC%8E
15、%E2%80%83%20XIAO%E2%80%83S%E2%80%83Y%EF%BC%8EThe%E2%80%83%20theORetical%E2%80%83%20basis%E2%80%83%20and%E2%80%83%20research%E2%80%83%0Aapplication%E2%80%83of%E2%80%83social%E2%80%83support%E2%80%83rating%E2%80%83scale%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJournal%E2%80%83%0Aof%E2%80%83Clinical%E2%80%83Psychiatry%EF%BC%8C1994%EF%BC%884%EF%BC%89%EF%BC%9A98-100%EF%BC%8E%E2%80%83%20XIAO%E2%80%83S%E2%80%83Y%EF%BC%8EThe%E2%80%83%20theORetical%E2%80%83%20basis%E2%80%83%20and%E2%80%83%20research%E2%80%83%0Aapplication%E2%80%83of%E2%80%83social%E2%80%83support%E2%80%83rating%E2%80%83scale%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJournal%E2%80%83%0Aof%E2%80%83Clinical%E2%80%83Psychiatry%EF%BC%8C1994%EF%BC%884%EF%BC%89%EF%BC%9A98-100%EF%BC%8E
16、ZHANG%E2%80%83Y%EF%BC%8CLI%E2%80%83X%EF%BC%8CBI%E2%80%83Y%EF%BC%8Cet%E2%80%83al%EF%BC%8EEffects%E2%80%83%20of%E2%80%83family%E2%80%83%0Afunction%EF%BC%8Cdepression%EF%BC%8Cand%E2%80%83self-perceived%E2%80%83burden%E2%80%83on%E2%80%83%0Aloneliness%E2%80%83in%E2%80%83patients%E2%80%83with%E2%80%83type%E2%80%832%E2%80%83diabetes%E2%80%83mellitus%EF%BC%9A%0AA%E2%80%83serial%E2%80%83multiple%E2%80%83mediation%E2%80%83model%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83%0APsychiatry%EF%BC%8C2023%EF%BC%8C23%EF%BC%881%EF%BC%89%EF%BC%9A636%EF%BC%8EZHANG%E2%80%83Y%EF%BC%8CLI%E2%80%83X%EF%BC%8CBI%E2%80%83Y%EF%BC%8Cet%E2%80%83al%EF%BC%8EEffects%E2%80%83%20of%E2%80%83family%E2%80%83%0Afunction%EF%BC%8Cdepression%EF%BC%8Cand%E2%80%83self-perceived%E2%80%83burden%E2%80%83on%E2%80%83%0Aloneliness%E2%80%83in%E2%80%83patients%E2%80%83with%E2%80%83type%E2%80%832%E2%80%83diabetes%E2%80%83mellitus%EF%BC%9A%0AA%E2%80%83serial%E2%80%83multiple%E2%80%83mediation%E2%80%83model%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83%0APsychiatry%EF%BC%8C2023%EF%BC%8C23%EF%BC%881%EF%BC%89%EF%BC%9A636%EF%BC%8E
17、BRAZIER%E2%80%83J%E2%80%83E%EF%BC%8CHARPER%E2%80%83R%EF%BC%8CJONES%E2%80%83N%E2%80%83M%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AValidating%E2%80%83the%E2%80%83SF-36%E2%80%83health%E2%80%83survey%E2%80%83questionnaire%EF%BC%9A%0ANew%E2%80%83outcome%E2%80%83measure%E2%80%83fOR%E2%80%83primary%E2%80%83care%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMJ%EF%BC%8C%0A1992%EF%BC%8C305%EF%BC%886846%EF%BC%89%EF%BC%9A160-164%EF%BC%8EBRAZIER%E2%80%83J%E2%80%83E%EF%BC%8CHARPER%E2%80%83R%EF%BC%8CJONES%E2%80%83N%E2%80%83M%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AValidating%E2%80%83the%E2%80%83SF-36%E2%80%83health%E2%80%83survey%E2%80%83questionnaire%EF%BC%9A%0ANew%E2%80%83outcome%E2%80%83measure%E2%80%83fOR%E2%80%83primary%E2%80%83care%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMJ%EF%BC%8C%0A1992%EF%BC%8C305%EF%BC%886846%EF%BC%89%EF%BC%9A160-164%EF%BC%8E
18、ZHANG%E2%80%83Z%EF%BC%8CLIN%E2%80%83R%EF%BC%8CQIU%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8EApplication%E2%80%83%20of%E2%80%83%0ADASS-21%E2%80%83in%E2%80%83Chinese%E2%80%83students%EF%BC%9AInvariance%E2%80%83testing%E2%80%83%0Aand%E2%80%83netwORk%E2%80%83analysis%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83Public%E2%80%83Health%EF%BC%8C%0A2024%EF%BC%8C24%EF%BC%881%EF%BC%89%EF%BC%9A2934%EF%BC%8EZHANG%E2%80%83Z%EF%BC%8CLIN%E2%80%83R%EF%BC%8CQIU%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8EApplication%E2%80%83%20of%E2%80%83%0ADASS-21%E2%80%83in%E2%80%83Chinese%E2%80%83students%EF%BC%9AInvariance%E2%80%83testing%E2%80%83%0Aand%E2%80%83netwORk%E2%80%83analysis%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83Public%E2%80%83Health%EF%BC%8C%0A2024%EF%BC%8C24%EF%BC%881%EF%BC%89%EF%BC%9A2934%EF%BC%8E
19、%E2%80%83%20LOVIBOND%E2%80%83S%E2%80%83H%EF%BC%8CAND%E2%80%83P%EF%BC%8EF%EF%BC%8ELOVIBOND%EF%BC%8EManual%E2%80%83%0Afor%E2%80%83the%E2%80%83Depression%E2%80%83Anxiety%E2%80%83Stress%E2%80%83Scales%EF%BC%88DASS%EF%BC%89%EF%BC%8E%0A2nd%E2%80%83ed%EF%BC%8E%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPsychology%E2%80%83Foundation%EF%BC%8C1995%EF%BC%8E%E2%80%83%20LOVIBOND%E2%80%83S%E2%80%83H%EF%BC%8CAND%E2%80%83P%EF%BC%8EF%EF%BC%8ELOVIBOND%EF%BC%8EManual%E2%80%83%0Afor%E2%80%83the%E2%80%83Depression%E2%80%83Anxiety%E2%80%83Stress%E2%80%83Scales%EF%BC%88DASS%EF%BC%89%EF%BC%8E%0A2nd%E2%80%83ed%EF%BC%8E%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPsychology%E2%80%83Foundation%EF%BC%8C1995%EF%BC%8E
20、HAO%E2%80%83R%EF%BC%8CJIN%E2%80%83H%EF%BC%8CZUO%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8EThe%E2%80%83%20multiple%E2%80%83%0Amediating%E2%80%83effect%E2%80%83of%E2%80%83family%E2%80%83health%E2%80%83and%E2%80%83perceived%E2%80%83social%E2%80%83%0Asupport%E2%80%83on%E2%80%83depressive%E2%80%83symptoms%E2%80%83in%E2%80%83older%E2%80%83adults%EF%BC%9A%0AA%E2%80%83cross-sectional%E2%80%83national%E2%80%83survey%E2%80%83in%E2%80%83China%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Affect%E2%80%83Disord%EF%BC%8C2023%EF%BC%88327%EF%BC%89%EF%BC%9A348-354%EF%BC%8EHAO%E2%80%83R%EF%BC%8CJIN%E2%80%83H%EF%BC%8CZUO%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8EThe%E2%80%83%20multiple%E2%80%83%0Amediating%E2%80%83effect%E2%80%83of%E2%80%83family%E2%80%83health%E2%80%83and%E2%80%83perceived%E2%80%83social%E2%80%83%0Asupport%E2%80%83on%E2%80%83depressive%E2%80%83symptoms%E2%80%83in%E2%80%83older%E2%80%83adults%EF%BC%9A%0AA%E2%80%83cross-sectional%E2%80%83national%E2%80%83survey%E2%80%83in%E2%80%83China%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Affect%E2%80%83Disord%EF%BC%8C2023%EF%BC%88327%EF%BC%89%EF%BC%9A348-354%EF%BC%8E
21、KONG%E2%80%83X%EF%BC%8CWU%E2%80%83Y%EF%BC%8CWANG%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8EAnalysis%E2%80%83%20of%E2%80%83%0Athe%E2%80%83%20prevalence%E2%80%83%20and%E2%80%83influencing%E2%80%83factors%E2%80%83%20of%E2%80%83%20anxiety%E2%80%83%0Aand%E2%80%83depression%E2%80%83in%E2%80%83the%E2%80%83Chinese%E2%80%83population%EF%BC%9AA%E2%80%83cross%02sectional%E2%80%83survey%EF%BC%BBJ%EF%BC%BD%EF%BC%8EHeliyon%EF%BC%8C2023%EF%BC%8C9%EF%BC%885%EF%BC%89%EF%BC%9A%0Ae15889%EF%BC%8EKONG%E2%80%83X%EF%BC%8CWU%E2%80%83Y%EF%BC%8CWANG%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8EAnalysis%E2%80%83%20of%E2%80%83%0Athe%E2%80%83%20prevalence%E2%80%83%20and%E2%80%83influencing%E2%80%83factors%E2%80%83%20of%E2%80%83%20anxiety%E2%80%83%0Aand%E2%80%83depression%E2%80%83in%E2%80%83the%E2%80%83Chinese%E2%80%83population%EF%BC%9AA%E2%80%83cross%02sectional%E2%80%83survey%EF%BC%BBJ%EF%BC%BD%EF%BC%8EHeliyon%EF%BC%8C2023%EF%BC%8C9%EF%BC%885%EF%BC%89%EF%BC%9A%0Ae15889%EF%BC%8E
22、ALMEIDA%E2%80%83D%E2%80%83M%EF%BC%8CRUSH%E2%80%83J%EF%BC%8CMOGLE%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0ALongitudinal%E2%80%83change%E2%80%83in%E2%80%83daily%E2%80%83stress%E2%80%83across%E2%80%8320%E2%80%83years%E2%80%83of%E2%80%83%0Aadulthood%EF%BC%9AResults%E2%80%83from%E2%80%83the%E2%80%83%20national%E2%80%83%20study%E2%80%83of%E2%80%83%20daily%E2%80%83%0Aexperiences%EF%BC%BBJ%EF%BC%BD%EF%BC%8EDev%E2%80%83Psychol%EF%BC%8C2023%EF%BC%8C59%EF%BC%883%EF%BC%89%EF%BC%9A%0A515-523%EF%BC%8EALMEIDA%E2%80%83D%E2%80%83M%EF%BC%8CRUSH%E2%80%83J%EF%BC%8CMOGLE%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0ALongitudinal%E2%80%83change%E2%80%83in%E2%80%83daily%E2%80%83stress%E2%80%83across%E2%80%8320%E2%80%83years%E2%80%83of%E2%80%83%0Aadulthood%EF%BC%9AResults%E2%80%83from%E2%80%83the%E2%80%83%20national%E2%80%83%20study%E2%80%83of%E2%80%83%20daily%E2%80%83%0Aexperiences%EF%BC%BBJ%EF%BC%BD%EF%BC%8EDev%E2%80%83Psychol%EF%BC%8C2023%EF%BC%8C59%EF%BC%883%EF%BC%89%EF%BC%9A%0A515-523%EF%BC%8E
23、张瑞君,李舟,亦佳佳,等.早期积极心理干预对DTC患者负性情绪和癌因性疲乏的影响[J].广州医药,2024,55(7):741-746,758.张瑞君,李舟,亦佳佳,等.早期积极心理干预对DTC患者负性情绪和癌因性疲乏的影响[J].广州医药,2024,55(7):741-746,758.
24、%E2%80%83%20THOITS%E2%80%83P%E2%80%83A%EF%BC%8EMechanisms%E2%80%83linking%E2%80%83%20social%E2%80%83ties%E2%80%83%20and%E2%80%83%0Asupport%E2%80%83to%E2%80%83physical%E2%80%83and%E2%80%83mental%E2%80%83health%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Health%E2%80%83%0ASoc%E2%80%83Behav%EF%BC%8C2011%EF%BC%8C52%EF%BC%882%EF%BC%89%EF%BC%9A145-161%EF%BC%8E%E2%80%83%20THOITS%E2%80%83P%E2%80%83A%EF%BC%8EMechanisms%E2%80%83linking%E2%80%83%20social%E2%80%83ties%E2%80%83%20and%E2%80%83%0Asupport%E2%80%83to%E2%80%83physical%E2%80%83and%E2%80%83mental%E2%80%83health%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Health%E2%80%83%0ASoc%E2%80%83Behav%EF%BC%8C2011%EF%BC%8C52%EF%BC%882%EF%BC%89%EF%BC%9A145-161%EF%BC%8E
25、HASLAM%E2%80%83C%EF%BC%8CHASLAM%E2%80%83S%E2%80%83A%EF%BC%8CJETTEN%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8ELife%E2%80%83%0AChange%EF%BC%8CSocial%E2%80%83Identity%EF%BC%8Cand%E2%80%83Health%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAnnu%E2%80%83%0ARev%E2%80%83Psychol%EF%BC%8C2021%EF%BC%8872%EF%BC%89%EF%BC%9A635-661%EF%BC%8EHASLAM%E2%80%83C%EF%BC%8CHASLAM%E2%80%83S%E2%80%83A%EF%BC%8CJETTEN%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8ELife%E2%80%83%0AChange%EF%BC%8CSocial%E2%80%83Identity%EF%BC%8Cand%E2%80%83Health%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAnnu%E2%80%83%0ARev%E2%80%83Psychol%EF%BC%8C2021%EF%BC%8872%EF%BC%89%EF%BC%9A635-661%EF%BC%8E
26、RING%E2%80%83D%EF%BC%8EMental%E2%80%83%20and%E2%80%83%20social%E2%80%83%20health%E2%80%83%20are%E2%80%83inseparable%E2%80%83%0Afrom%E2%80%83physical%E2%80%83health%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Bone%E2%80%83Joint%E2%80%83Surg%E2%80%83Am%EF%BC%8C%0A2021%EF%BC%8C103%EF%BC%8811%EF%BC%89%EF%BC%9A951-952%EF%BC%8ERING%E2%80%83D%EF%BC%8EMental%E2%80%83%20and%E2%80%83%20social%E2%80%83%20health%E2%80%83%20are%E2%80%83inseparable%E2%80%83%0Afrom%E2%80%83physical%E2%80%83health%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Bone%E2%80%83Joint%E2%80%83Surg%E2%80%83Am%EF%BC%8C%0A2021%EF%BC%8C103%EF%BC%8811%EF%BC%89%EF%BC%9A951-952%EF%BC%8E
27、%E2%80%83DOMENECH-ABELLA%E2%80%83J%EF%BC%8CLARA%E2%80%83E%EF%BC%8CRUBIO%02VALERA%E2%80%83M%EF%BC%8Cet%E2%80%83al%EF%BC%8ELoneliness%E2%80%83%20and%E2%80%83%20depression%E2%80%83in%E2%80%83%0Athe%E2%80%83elderly%EF%BC%9AThe%E2%80%83role%E2%80%83of%E2%80%83social%E2%80%83network%EF%BC%BBJ%EF%BC%BD%EF%BC%8ESoc%E2%80%83%0APsychiatry%E2%80%83Psychiatr%E2%80%83Epidemiol%EF%BC%8C2017%EF%BC%8C52%EF%BC%884%EF%BC%89%EF%BC%9A%0A381-390%EF%BC%8E%E2%80%83DOMENECH-ABELLA%E2%80%83J%EF%BC%8CLARA%E2%80%83E%EF%BC%8CRUBIO%02VALERA%E2%80%83M%EF%BC%8Cet%E2%80%83al%EF%BC%8ELoneliness%E2%80%83%20and%E2%80%83%20depression%E2%80%83in%E2%80%83%0Athe%E2%80%83elderly%EF%BC%9AThe%E2%80%83role%E2%80%83of%E2%80%83social%E2%80%83network%EF%BC%BBJ%EF%BC%BD%EF%BC%8ESoc%E2%80%83%0APsychiatry%E2%80%83Psychiatr%E2%80%83Epidemiol%EF%BC%8C2017%EF%BC%8C52%EF%BC%884%EF%BC%89%EF%BC%9A%0A381-390%EF%BC%8E
28、MUHAMMAD%E2%80%83T%EF%BC%8CMAURYA%E2%80%83P%EF%BC%8ESocial%E2%80%83%20suppo%20rt%E2%80%83%0Amoderates%E2%80%83the%E2%80%83association%E2%80%83of%E2%80%83functional%E2%80%83difficulty%E2%80%83with%E2%80%83major%E2%80%83%20depression%E2%80%83%20among%E2%80%83%20community-dwelling%E2%80%83%20older%E2%80%83%0Aadults%EF%BC%9AEvidence%E2%80%83from%E2%80%83LASI%EF%BC%8C2017-18%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83%0APsychiatry%EF%BC%8C2022%EF%BC%8C22%EF%BC%881%EF%BC%89%EF%BC%9A317%EF%BC%8EMUHAMMAD%E2%80%83T%EF%BC%8CMAURYA%E2%80%83P%EF%BC%8ESocial%E2%80%83%20suppo%20rt%E2%80%83%0Amoderates%E2%80%83the%E2%80%83association%E2%80%83of%E2%80%83functional%E2%80%83difficulty%E2%80%83with%E2%80%83major%E2%80%83%20depression%E2%80%83%20among%E2%80%83%20community-dwelling%E2%80%83%20older%E2%80%83%0Aadults%EF%BC%9AEvidence%E2%80%83from%E2%80%83LASI%EF%BC%8C2017-18%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83%0APsychiatry%EF%BC%8C2022%EF%BC%8C22%EF%BC%881%EF%BC%89%EF%BC%9A317%EF%BC%8E
29、%E2%80%83%20ROSKOSCHINSKI%E2%80%83A%EF%BC%8CLIANG%E2%80%83W%EF%BC%8CDUAN%E2%80%83Y%EF%BC%8Cet%E2%80%83%0Aal%EF%BC%8ELoneliness%E2%80%83%20and%E2%80%83%20depression%E2%80%83in%E2%80%83%20older%E2%80%83%20adults%E2%80%83with%E2%80%83%0Amultimorbidity%EF%BC%9AThe%E2%80%83%20role%E2%80%83of%E2%80%83%20self-efficacy%E2%80%83and%E2%80%83%20social%E2%80%83%0Asupport%EF%BC%BBJ%EF%BC%BD%EF%BC%8EFront%E2%80%83Psychiatry%EF%BC%8C2023%EF%BC%8814%EF%BC%89%EF%BC%9A%0A1232067%EF%BC%8E%E2%80%83%20ROSKOSCHINSKI%E2%80%83A%EF%BC%8CLIANG%E2%80%83W%EF%BC%8CDUAN%E2%80%83Y%EF%BC%8Cet%E2%80%83%0Aal%EF%BC%8ELoneliness%E2%80%83%20and%E2%80%83%20depression%E2%80%83in%E2%80%83%20older%E2%80%83%20adults%E2%80%83with%E2%80%83%0Amultimorbidity%EF%BC%9AThe%E2%80%83%20role%E2%80%83of%E2%80%83%20self-efficacy%E2%80%83and%E2%80%83%20social%E2%80%83%0Asupport%EF%BC%BBJ%EF%BC%BD%EF%BC%8EFront%E2%80%83Psychiatry%EF%BC%8C2023%EF%BC%8814%EF%BC%89%EF%BC%9A%0A1232067%EF%BC%8E
30、%E2%80%83%20S%C3%81NCHEZ-MORENO%E2%80%83E%EF%BC%8CGALLARDO-PERALTA%E2%80%83L%E2%80%83%0AP%EF%BC%8EIncome%E2%80%83inequalities%EF%BC%8Csocial%E2%80%83support%E2%80%83and%E2%80%83depressive%E2%80%83%0Asymptoms%E2%80%83among%E2%80%83older%E2%80%83adults%E2%80%83in%E2%80%83Europe%EF%BC%9AA%E2%80%83multilevel%E2%80%83%0Across-sectional%E2%80%83study%EF%BC%BBJ%EF%BC%BD%EF%BC%8EEur%E2%80%83J%E2%80%83Ageing%EF%BC%8C2022%EF%BC%8C19%0A%EF%BC%883%EF%BC%89%EF%BC%9A663-675%EF%BC%8E%E2%80%83%20S%C3%81NCHEZ-MORENO%E2%80%83E%EF%BC%8CGALLARDO-PERALTA%E2%80%83L%E2%80%83%0AP%EF%BC%8EIncome%E2%80%83inequalities%EF%BC%8Csocial%E2%80%83support%E2%80%83and%E2%80%83depressive%E2%80%83%0Asymptoms%E2%80%83among%E2%80%83older%E2%80%83adults%E2%80%83in%E2%80%83Europe%EF%BC%9AA%E2%80%83multilevel%E2%80%83%0Across-sectional%E2%80%83study%EF%BC%BBJ%EF%BC%BD%EF%BC%8EEur%E2%80%83J%E2%80%83Ageing%EF%BC%8C2022%EF%BC%8C19%0A%EF%BC%883%EF%BC%89%EF%BC%9A663-675%EF%BC%8E
31、LIN%E2%80%83X%EF%BC%8CXU%E2%80%83G%EF%BC%8CCHEN%E2%80%83G%EF%BC%8Cet%E2%80%83al%EF%BC%8ESelf-perceived%E2%80%83%0Aburden%E2%80%83predicts%E2%80%83lower%E2%80%83quality%E2%80%83of%E2%80%83life%E2%80%83in%E2%80%83advanced%E2%80%83cancer%E2%80%83%0Apatients%EF%BC%9AThe%E2%80%83mediating%E2%80%83role%E2%80%83of%E2%80%83existential%E2%80%83distress%E2%80%83and%E2%80%83%0Aanxiety%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83Geriatr%EF%BC%8C2022%EF%BC%8C22%EF%BC%881%EF%BC%89%EF%BC%9A803%EF%BC%8ELIN%E2%80%83X%EF%BC%8CXU%E2%80%83G%EF%BC%8CCHEN%E2%80%83G%EF%BC%8Cet%E2%80%83al%EF%BC%8ESelf-perceived%E2%80%83%0Aburden%E2%80%83predicts%E2%80%83lower%E2%80%83quality%E2%80%83of%E2%80%83life%E2%80%83in%E2%80%83advanced%E2%80%83cancer%E2%80%83%0Apatients%EF%BC%9AThe%E2%80%83mediating%E2%80%83role%E2%80%83of%E2%80%83existential%E2%80%83distress%E2%80%83and%E2%80%83%0Aanxiety%EF%BC%BBJ%EF%BC%BD%EF%BC%8EBMC%E2%80%83Geriatr%EF%BC%8C2022%EF%BC%8C22%EF%BC%881%EF%BC%89%EF%BC%9A803%EF%BC%8E
32、%E2%80%83%20HANDING%E2%80%83E%E2%80%83P%EF%BC%8CSTROBL%E2%80%83C%EF%BC%8CJIAO%E2%80%83Y%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0APredictors%E2%80%83%20of%E2%80%83%20depression%E2%80%83%20among%E2%80%83%20middle-aged%E2%80%83%20and%E2%80%83%0Aolder%E2%80%83men%E2%80%83and%E2%80%83women%E2%80%83in%E2%80%83Europe%EF%BC%9AA%E2%80%83machine%E2%80%83learning%E2%80%83%0Aapproach%EF%BC%BBJ%EF%BC%BD%EF%BC%8ELancet%E2%80%83Reg%E2%80%83Health%E2%80%83Eur%EF%BC%8C2022%0A%EF%BC%8818%EF%BC%89%EF%BC%9A100391%EF%BC%8E%E2%80%83%20HANDING%E2%80%83E%E2%80%83P%EF%BC%8CSTROBL%E2%80%83C%EF%BC%8CJIAO%E2%80%83Y%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0APredictors%E2%80%83%20of%E2%80%83%20depression%E2%80%83%20among%E2%80%83%20middle-aged%E2%80%83%20and%E2%80%83%0Aolder%E2%80%83men%E2%80%83and%E2%80%83women%E2%80%83in%E2%80%83Europe%EF%BC%9AA%E2%80%83machine%E2%80%83learning%E2%80%83%0Aapproach%EF%BC%BBJ%EF%BC%BD%EF%BC%8ELancet%E2%80%83Reg%E2%80%83Health%E2%80%83Eur%EF%BC%8C2022%0A%EF%BC%8818%EF%BC%89%EF%BC%9A100391%EF%BC%8E
33、TANG%E2%80%83S%E2%80%83T%EF%BC%8CCHEN%E2%80%83J%E2%80%83S%EF%BC%8CCHOU%E2%80%83W%E2%80%83C%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0APrevalence%E2%80%83of%E2%80%83%20severe%E2%80%83%20depressive%E2%80%83%20symptoms%E2%80%83increases%E2%80%83%0Aas%E2%80%83%20death%E2%80%83%20approaches%E2%80%83%20and%E2%80%83is%E2%80%83%20associated%E2%80%83with%E2%80%83%20disease%E2%80%83%0Aburden%EF%BC%8Ctangible%E2%80%83social%E2%80%83support%EF%BC%8Cand%E2%80%83high%E2%80%83self%02perceived%E2%80%83burden%E2%80%83to%E2%80%83others%EF%BC%BBJ%EF%BC%BD%EF%BC%8ESuppORt%E2%80%83%20Care%E2%80%83%0ACancer%EF%BC%8C2016%EF%BC%8C24%EF%BC%881%EF%BC%89%EF%BC%9A83-91%EF%BC%8ETANG%E2%80%83S%E2%80%83T%EF%BC%8CCHEN%E2%80%83J%E2%80%83S%EF%BC%8CCHOU%E2%80%83W%E2%80%83C%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0APrevalence%E2%80%83of%E2%80%83%20severe%E2%80%83%20depressive%E2%80%83%20symptoms%E2%80%83increases%E2%80%83%0Aas%E2%80%83%20death%E2%80%83%20approaches%E2%80%83%20and%E2%80%83is%E2%80%83%20associated%E2%80%83with%E2%80%83%20disease%E2%80%83%0Aburden%EF%BC%8Ctangible%E2%80%83social%E2%80%83support%EF%BC%8Cand%E2%80%83high%E2%80%83self%02perceived%E2%80%83burden%E2%80%83to%E2%80%83others%EF%BC%BBJ%EF%BC%BD%EF%BC%8ESuppORt%E2%80%83%20Care%E2%80%83%0ACancer%EF%BC%8C2016%EF%BC%8C24%EF%BC%881%EF%BC%89%EF%BC%9A83-91%EF%BC%8E
1、广东省基础与应用基础研究基金面上项目(2023A1515011767);广州市科技计划项目(2024A04J4015);广州市第一人民医院红棉计划项目(2023HL11)()
上一篇
下一篇
出版者信息








《广州医药》公众号
目录